annual cash & cash equivalents:
$269.50M+$73.60M(+37.57%)Summary
- As of today (May 20, 2025), SGRY annual cash & cash equivalents is $269.50 million, with the most recent change of +$73.60 million (+37.57%) on December 31, 2024.
- During the last 3 years, SGRY annual cash & cash equivalents has fallen by -$120.40 million (-30.88%).
- SGRY annual cash & cash equivalents is now -30.88% below its all-time high of $389.90 million, reached on December 31, 2021.
Performance
SGRY Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$229.30M-$40.20M(-14.92%)Summary
- As of today (May 20, 2025), SGRY quarterly cash & cash equivalents is $229.30 million, with the most recent change of -$40.20 million (-14.92%) on March 31, 2025.
- Over the past year, SGRY quarterly cash & cash equivalents has increased by +$44.10 million (+23.81%).
- SGRY quarterly cash & cash equivalents is now -57.69% below its all-time high of $541.90 million, reached on March 31, 2021.
Performance
SGRY quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SGRY Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.6% | +23.8% |
| 3 y3 years | -30.9% | -39.5% |
| 5 y5 years | +190.7% | +17.8% |
SGRY Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.9% | +37.6% | -39.5% | +48.1% |
| 5 y | 5-year | -30.9% | +190.7% | -57.7% | +48.1% |
| alltime | all time | -30.9% | +1968.9% | -57.7% | +378.6% |
SGRY Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $229.30M(-14.9%) |
| Dec 2024 | $269.50M(+37.6%) | $269.50M(+21.5%) |
| Sep 2024 | - | $221.80M(+3.9%) |
| Jun 2024 | - | $213.50M(+15.3%) |
| Mar 2024 | - | $185.20M(-5.5%) |
| Dec 2023 | $195.90M(-30.8%) | $195.90M(-17.0%) |
| Sep 2023 | - | $236.00M(+33.0%) |
| Jun 2023 | - | $177.40M(-27.7%) |
| Mar 2023 | - | $245.50M(-13.2%) |
| Dec 2022 | $282.90M(-27.4%) | $282.90M(+82.8%) |
| Sep 2022 | - | $154.80M(-31.9%) |
| Jun 2022 | - | $227.40M(-40.0%) |
| Mar 2022 | - | $378.90M(-2.8%) |
| Dec 2021 | $389.90M(+22.6%) | $389.90M(+18.0%) |
| Sep 2021 | - | $330.40M(-28.9%) |
| Jun 2021 | - | $464.80M(-14.2%) |
| Mar 2021 | - | $541.90M(+70.5%) |
| Dec 2020 | $317.90M(+242.9%) | $317.90M(-29.4%) |
| Sep 2020 | - | $450.00M(+37.9%) |
| Jun 2020 | - | $326.30M(+67.7%) |
| Mar 2020 | - | $194.60M(+109.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $92.70M(-49.7%) | $92.70M(-16.7%) |
| Sep 2019 | - | $111.30M(-5.2%) |
| Jun 2019 | - | $117.40M(-17.6%) |
| Mar 2019 | - | $142.50M(-22.7%) |
| Dec 2018 | $184.30M(+5.4%) | $184.30M(+132.9%) |
| Sep 2018 | - | $79.12M(-17.6%) |
| Jun 2018 | - | $96.07M(-14.8%) |
| Mar 2018 | - | $112.82M(-35.5%) |
| Dec 2017 | $174.91M(+151.0%) | $174.91M(-12.4%) |
| Sep 2017 | - | $199.70M(+250.1%) |
| Jun 2017 | - | $57.03M(+1.9%) |
| Mar 2017 | - | $55.97M(-19.7%) |
| Dec 2016 | $69.70M(+20.3%) | $69.70M(+26.2%) |
| Sep 2016 | - | $55.21M(+7.0%) |
| Jun 2016 | - | $51.60M(-61.8%) |
| Mar 2016 | - | $135.05M(+133.1%) |
| Dec 2015 | $57.93M(-22.7%) | $57.93M(+1.9%) |
| Sep 2015 | - | $56.85M(+18.7%) |
| Jun 2015 | - | $47.91M(-36.1%) |
| Dec 2014 | $74.92M(+475.2%) | $74.92M |
| Dec 2013 | $13.03M | - |
FAQ
- What is Surgery Partners annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Surgery Partners?
- What is Surgery Partners annual cash & cash equivalents year-on-year change?
- What is Surgery Partners quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Surgery Partners?
- What is Surgery Partners quarterly cash & cash equivalents year-on-year change?
What is Surgery Partners annual cash & cash equivalents?
The current annual cash & cash equivalents of SGRY is $269.50M
What is the all time high annual cash & cash equivalents for Surgery Partners?
Surgery Partners all-time high annual cash & cash equivalents is $389.90M
What is Surgery Partners annual cash & cash equivalents year-on-year change?
Over the past year, SGRY annual cash & cash equivalents has changed by +$73.60M (+37.57%)
What is Surgery Partners quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SGRY is $229.30M
What is the all time high quarterly cash & cash equivalents for Surgery Partners?
Surgery Partners all-time high quarterly cash & cash equivalents is $541.90M
What is Surgery Partners quarterly cash & cash equivalents year-on-year change?
Over the past year, SGRY quarterly cash & cash equivalents has changed by +$44.10M (+23.81%)